№ files_lp_4_process_3_136059
File format: docx Character count: 65096 File size: 76 KB
GLP-1 receptor agonists have proven efficacy in reducing cardiovascular events in high-risk type 2 diabetes patients, but their underuse in clinical practice, especially in those with atherosclerotic cardiovascular disease, remains a significant issue.
Year: 2024
Region / City: International
Topic: Type 2 diabetes, Cardiovascular disease, GLP-1 receptor agonists
Document Type: Expert Opinion / Commentary
Organization / Institution: N/A
Author: Expert opinion
Target Audience: Healthcare professionals, Researchers
Period of Action: N/A
Date of Approval: N/A
Date of Changes: N/A
Keywords: Atherosclerotic cardiovascular disease, Cardiovascular outcome trial, GLP-1 receptor agonist, Observational studies, Real-world clinical practice
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.